Related Experiment Video
Updated: May 10, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Reducing perioperative cardiac morbidity and mortality: is this the right goal?
Emily K Gordon1, Lee A Fleisher
1Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Insights
Elevated troponin levels after noncardiac surgery indicate higher risks. Lower troponin elevations are now recognized as significant, aiding in identifying patients needing interventions to reduce mortality.
Area of Science:
- Cardiology
- Perioperative Medicine
- Cardiac Biomarkers
Background:
- Noncardiac surgery leads to significant annual mortality and perioperative cardiac events.
- Accurate risk stratification is crucial due to the growing number of surgical procedures.
- Perioperative myocardial ischemia/necrosis is a key concern in surgical patients.
Purpose of the Study:
- To review the significance of troponin elevation after noncardiac surgery.
- To highlight the importance of identifying patients at high risk for adverse cardiac events.
- To discuss interventions for improving outcomes in at-risk surgical patients.
Main Methods:
- Review of recent publications on troponin levels and outcomes after noncardiac surgery.
- Analysis of the association between troponin elevation and perioperative morbidity/mortality.
- Evaluation of the diagnostic threshold for pathological troponin elevation.
Main Results:
- Increased troponin following noncardiac surgery is linked to higher perioperative morbidity and mortality.
- The threshold for troponin elevation indicating increased risk is lower than previously thought.
- Troponin levels can identify patients with elevated risk for adverse events post-surgery.
Conclusions:
- Troponin elevation after noncardiac surgery can identify high-risk patients.
- Early identification allows for targeted interventions to improve patient outcomes.
- Interventions may reduce in-hospital, 30-day, and long-term mortality in at-risk patients.
Purpose Of Review:
One million people die annually following noncardiac surgery and 4% of patients suffer an adverse cardiac event after surgery. As the number of people having surgery grows, our ability to risk stratify patients becomes more important, particularly in the setting of perioperative myocardial ischemia/necrosis.
Recent Findings:
In recent publications, an increased troponin following noncardiac surgery has been associated with a higher morbidity/mortality in the perioperative setting. The level of troponin elevation associated with increased morbidity/mortality is now believed to be far lower than was previously considered to be pathologic.
Summary:
The presence of troponin elevations following noncardiac surgery, particularly in at-risk patients, may enable practitioners to better identify high-risk patients in the postoperative setting. After recognizing those patients at increased risk for poor outcomes, practitioners can then make interventions, which may decrease the patients' in-hospital, 30-day and potentially long-term mortality.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Pericarditis III: Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
